EXOZYMES Insider Buying Signals Strong Confidence Ahead of Investor Summit
EXOZYMES insider buying shows strong confidence in its pipeline and upcoming investor summit, hinting at a possible rebound from its 52‑week low.
4 minutes to read
EXOZYMES INC
ExoZymes Insider Buy Signals Confidence Ahead of Investor Summit
ExoZymes insider Korman Paz buys 32,964 shares after RSU vesting, signaling confidence in upcoming Investor Summit catalysts and potential rebound.
2 minutes to read
eXoZymes Insider Sales & IPO Reveal Strategic Boost for Exozyme Therapy Development
eXoZymes insider trades reveal a balanced strategy: CFO sales, upcoming Nasdaq IPO, and a robust exozyme therapy roadmap backed by AI, digital biomarkers, and value‑based pricing.
5 minutes to read